Clinical use of genome-wide Hi-C sequencing for assessment of structural variants in diffuse large B-cell lymphoma.
Michaels, et al.
ASH 2025 - Orlando, FL
Hi-C FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma
Xu-Monette, et al.
ASH 2025 - Orlando, FL
Application of Hi-c sequencing to detect cryptic and novel structural aberrations in lymphoid neoplasms
Rozenova, et al.
ASH 2025 - Orlando, FL
Cytogenetic Advances in NHL Diagnosis by Leveraging Hi-C Sequencing
Sikkink, et al.
AMP 2025 - Boston, MA
Hi-C FFPE Sequencing for Detection of Fusions and Rearrangements that are Diagnostic, Prognostic, and Therapeutic Biomarkers in Lymphoma
Hastie, et al.
Lymphoma, Leukemia & Myeloma Congress 2025 - NY, NY
Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH
Liang, et al.
Genes (Basel). 16(9):1093.
Molecular Analysis of Driver Negative Lung Cancer for Rearrangements and Fusions Using a New HiC Sequencing Assay
Ricketts, et al.
2025 World Conference on Lung Cancer - Barcelona, Spain
Aventa Lymphoma based on Hi-C FFPE Sequencing is an Alternative to FISH and Detects Additional Variants Informing Diagnosis and Therapy in Lymphomas
Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX
Aventa FusionPlus based on Hi-C FFPE Sequencing Detects Fusions Genome-Wide with High Sensitivity in Solid Tumors
Hastie, et al.
16th Annual Meeting of the Cancer Genomics Consortium - Houston, TX
